Eton Pharmaceuticals, Inc. (ETON) vs Kestra Medical Technologies, Ltd. (KMTS)
A side-by-side comparison of Eton Pharmaceuticals, Inc. and Kestra Medical Technologies, Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ETON
Eton Pharmaceuticals, Inc.
$54.66HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT
KMTS
Kestra Medical Technologies, Ltd.
$27.58HealthcareDelayed quote: Oct 6, 2026, 10:38 AM EDT
Total return — ETON vs KMTS
growth of $100 · dividends reinvested · last 2yETON +285.4% (+96.3%/yr)KMTS +29.8% (+13.9%/yr)ETON compounded faster over this window
ETON KMTS
ETON vs KMTS: by the numbers
- •KMTS is the larger company ($1.62B vs $1.50B market cap).
- •ETON is profitable (12.02% net margin) while KMTS runs a net loss (-140.43%).
Metrics side by side
Valuation
| Metric | ETON | KMTS |
|---|---|---|
| P/E ratio | 142.11 | N/A |
| Forward P/E | 50.26 | N/A |
| P/S ratio | 14.18 | 15.14 |
| P/B ratio | 32.14 | 7.27 |
| EV / EBITDA | 71.90 | N/A |
| FCF yield | 0.98% | N/A |
Profitability
| Metric | ETON | KMTS |
|---|---|---|
| Gross margin | 57.87% | 53.89% |
| Operating margin | 0.09% | -134.48% |
| Net margin | 12.02% | -140.43% |
| ROE | 27.24% | -67.40% |
| ROIC | 20.41% | -47.99% |
Growth (annualized)
| Metric | ETON | KMTS |
|---|---|---|
| Revenue CAGR (5Y) | 47.98% | N/A |
| Total return CAGR (5Y) | 63.04% | N/A |
Frequently asked
- Is ETON or KMTS more profitable?
- ETON runs the higher net margin — ETON at 12.02% versus KMTS at -140.43%.
Go deeper
Dig into the metrics
Eton Pharmaceuticals P/E ratioEton Pharmaceuticals ROEKestra Medical Technologies ROEEton Pharmaceuticals operating marginKestra Medical Technologies operating marginEton Pharmaceuticals revenue growthKestra Medical Technologies revenue growthEton Pharmaceuticals free cash flowKestra Medical Technologies free cash flow
Eton Pharmaceuticals & Kestra Medical Technologies appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.